Regeneron announces $3 billion share repurchase program

Tarrytown, n.y., nov. 12, 2021 /prnewswire/ -- regeneron pharmaceuticals, inc. (nasdaq: regn) today announced that its board of directors authorized a share repurchase program of up to $3 billion of the company's outstanding common stock.
REGN Ratings Summary
REGN Quant Ranking